Brain Natriuretic Peptide is a Prognostic Parameter in Chronic Lung Disease Hanno H. Leuchte, Rainer A. Baumgartner, Michal El Nounou, Michael Vogeser,

Slides:

Advertisements

Similar presentations

Ipertensione polmonare

Advertisements

Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure Fonarow GC et al. J Am Coll Cardiol 2007; 49(19):

Weaning failure of cardiac origin

M. Dres, J-L. Teboul, N. Anguel, L. Guerin, C. Richard, X. Monnet

Haemodynamic Monitoring

Student’s Research Group at the Department of Internal Medicine, Hypertension and Angiology The Medical University in Warsaw PULMONARY EMBOLISM – TOUGH.

Coinvolgimento polmonare nella sclerosi sistemica Marco Matucci Cerinic Departments of Rheumatology AVC BioMedicine & Division of Rheumatology AOUC Medicine,

Doppler Echocardiography Overestimates Pulmonary Hypertension in Patients with Scleroderma Interstitial Lung Disease Kevin M Chan 1, Elena Tishkowski 2,

CAMPUS GROSSHADERN - HERZCHIRURGISCHE KLINIK UND POLIKLINIK HERZKLINIK AM AUGUSTINUM ECMO as Bridge to Lung Transplant – Ambulatory V/V&V/VA ECMO: How.

Congestive heart failure

Prevalence of PAH in SSc ReferenceMethodologyDiagnosisPAH prevalence Mukerjee; 2003, UK n = 722, single center Prospective RHC12%

BNP in Diastolic Heart Failure Jon Wilson Mercer Pharm D Candidate C/O 2012.

Heart Failure Whistle Stop Talks No. 2 Classification Implications Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.

JONATHAN MANT, MD; ABDALLAH AL-MOHAMMAD, MD; SHARON SWAIN, BA, PHD; AND PHILIPPE LARAMEE,DC,MSC, FOR THE GUIDELINE DEVELOPMENT GROUP CHRIS FONTIMAYOR MS-III.

Current Management of Heart Failure GP clinical update 17 th June 2015 Dr Raj Bilku Consultant Cardiologist Clinical Lead Cardiology QEH.

The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis Following Myocardial Infarction: The VALIANT Echo Study Anil Verma,

Monitoring Fluid Responsiveness Murat Sungur, MD Erciyes University Medical School Department of Medicine Division of Critical Care Medicine.

Haemodynamic Monitoring Theory and Practice. 2 Haemodynamic Monitoring A.Physiological Background B.Monitoring C.Optimizing the Cardiac Output D.Measuring.

Target Study Cardiac resynchronization therapy (CRT) is an established treatment for advanced heart failure symptoms, impaired LV systolic function, and.

Clinical Features and Ultrasound Parameters in Pulmonary Arterial Hypertension, in Pediatric Cardiology Author: Gáspár Hanga 1 Scientific coordinators:

Chronic Heart Failure – An Update T P Chua Royal Surrey County Hospital, Guildford St George’s Hospital, London.

Plasma soluble receptor for advanced glycation end products (sRAGE) predicts survival in critically ill patients with systemic inflammatory response syndrome.

Exercise Testing – clinical utility Sudhir Rao Respiratory registrar.

Kimberly Dunbar, PA-S2 Follow-up of Cardiovascular Risk Markers in Hypertensive Patients Treated with Irbesartan: Results of the i-SEARCH Plus Registry.

All Rights Reserved, Duke Medicine 2008 Mechanical Dyssynchrony Defined by Phase Analysis from GSPECT: Does It Predict Mortality? Paul L. Hess, MD; Linda.

Introduction BACKGROUND  N on-sustained VT (NSVT) is a known risk factor for poor outcomes in adults with HCM and diastolic dysfunction is linked to poor.

The percentage of values for cardiac troponin (cTn)T associated with elevated values for a point-of-care assay with less sensitivity and precision: the.

Introduction Measuring the cardiac index using ultrasound dilution during hemodialysis (HD) can be used to detect patients with an excessive access flow.

TAHAR EL KANDOUSSI, SARA ECHERKI, NAWAL DOGHMI, MOHAMED CHERTI. SEcurite de l’Echocardiographie de stress : plutôt l’effort. Cardiology B Department, Ibn.

R1 정수웅.  Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive, fibrosing interstitial pneumonia of unknown cause that occurs.

Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients with Heart Failure with preserved Ejection Fraction Effect of Spironolactone.

Prevalence of preserved left ventricular function among patients admitted for pulmonary oedema F.HAZIZA, N.COHEN, J.F.LANDAU, A.C.GUIOMARD. Service de.

WELCOME BNP testing. Aims of this education package Better understanding of what BNP testing is How to appropriately use the test How to request the.

The CHART-2 Study (The Chronic Heart Failure Analysis and Registry in the Tohoku District 2) Source Shiba N, Nochioka K, Miura M, et al. Trend of westernization.

Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,

Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Management of Pulmonary Embolism: An Update J Am.

Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of B-type natriuretic peptide in the diagnosis.

Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic Value of RV Function Before and After.

Salome schafroth Torok, MD; Jorg D.Leuppi, MD; Florent Baty, PhD; Michael Tamm, MD, FCCP; and Prashant N. Chhajed,MD Chest 2008;133; ;Prepublished.

Eur Respir J 2010; 36: 819–825 DOI: / Elevated brain natriuretic peptide predicts mortality in interstitial lung disease R1 김 광.

Prognostic Importance of Hyponatremia in Patients with Acute Pulmonary Embolism 호흡기 내과 R1 박 지 윤 Nathalie Scherz1, Jose Labarere2, Marie Mean1, Said A.

R2 김재민 / Prof. 박명재 Journal conference 1.

Fig. 1 Microvascular dysfunction, characterized by vasomotor alterations and tissue ischaemia, and subsequent microvessel damage is the primum movens of.

Cardiac Causes of Maternal Death

Title Rebecca Brown, MD Date.

Department of Respiratory Medicine

Catriona Clark and Clare MacRae

Maternal cardiac function in twin pregnancies compared with singleton pregnancies. Makiko Kato, Yu Yaegashi, Shinji Monoe, Takuji Ueno, Takuma Yamada,

Acromegalic cardiomyopathy: A case report

Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease:

Objectives Early initiation of continuous renal replacement therapy

by Victor R. Gordeuk, Oswaldo L. Castro, and Roberto F. Machado

Are Direct Oral Anticoagulants Appropriate for PAH?

Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL.

Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome.

Brian P. Shapiro, MD, Horng H. Chen, MD, John C

Sexual Activity and Chronic Heart Failure

Cohort identification and exclusion.

Severe pulmonary hypertension (PH) in interstitial lung disease (ILD) stepwise composite echocardiographic score. Severe pulmonary hypertension (PH) in.

Neal A. Chatterjee et al. JCHF 2014;2:

Volume 71, Issue 6, Pages (March 2007)

Prevalence of comorbidities in pooled studies of patients with chronic obstructive pulmonary disease (COPD). Prevalence of comorbidities in pooled studies.

Risk assessment and treat-to-target approach for pulmonary arterial hypertension. Risk assessment and treat-to-target approach for pulmonary arterial hypertension.

The Research Question Heart failure (HF) and atrial fibrillation (AF) frequently coexist and are associated with many adverse outcomes HF and AF share.

Catriona Clark and Clare MacRae

Prevalence of different aetiologies of pulmonary hypertension (PH) in the paediatric population (results from national registries and paediatric cohorts).

When we compared cardiac volumes (ED and ES) between those with high BNP levels (BNP >400 pg/mL) and low BNP (

A–c) Chest computed tomography excluding acute lung embolism and parenchymal lung disease and d–g) echocardiography performed during diagnostic work-up.

Schematic diagram of the DETECT study [56].

Presentation transcript:

Brain Natriuretic Peptide is a Prognostic Parameter in Chronic Lung Disease Hanno H. Leuchte, Rainer A. Baumgartner, Michal El Nounou, Michael Vogeser, Claus Neurohr,Michael Trautnitz, and Juergen Behr Division of Pulmonary Diseases, Department of Internal Medicine I, and Department of Clinical Chemistry, Ludwig Maximilians University, Klinikum Grosshadern, Munich, Germany Am J Respir Crit Care Med Vol 173. pp 744–750, 2006

Background 1.Hypoxemia 2.Pulmonary vasoconstriction 3.Pulmonary hypertension 4.Right ventricular hypertrophy 5.Impaired cardiac function

Background BNP BNP Left ventricular heart failure Left ventricular heart failure Pulmonary arterial hypertension with CLD Pulmonary arterial hypertension with CLD BNP & CLD BNP & CLD Prognostic marker Prognostic marker Screening parameter of pulmonary hypertension Screening parameter of pulmonary hypertension

Methods Prospective study of 176 patients between March 2001 and June 2005 Prospective study of 176 patients between March 2001 and June 2005 Patients who were scheduled for Rt. Heart failure Patients who were scheduled for Rt. Heart failure Thromboemboic disease, Left heart failure Thromboemboic disease, Left heart failure PAP <35 mmHg : advanced or significant PH PAP <35 mmHg : advanced or significant PH Lung function testing, blood sampling and BNP study Lung function testing, blood sampling and BNP study

24.29 month month

Discussion Elevated BNP levels predicted survival BNP was superior to predict mortality : severe hypoxemia, lung volumes Excluded significant Lt. heart disease Limitations : echocardiography patients who were scheduled for right heart catheter to rule out PH a broad spectrum of lung diseases and cannot conclude on the prevalence of PH in a distinct lung disease

Conclusion Plasma BNP : noninvasive detection of significant PH with high accuracy and can be suggested as a screening test. Plasma BNP : noninvasive detection of significant PH with high accuracy and can be suggested as a screening test. BNP allows an assessment of the relevance of PH and could serve as a useful BNP allows an assessment of the relevance of PH and could serve as a useful prognostic parameter in chronic lung disease. prognostic parameter in chronic lung disease.